Several other equities analysts have also issued reports on the stock. Barclays restated a neutral rating on shares of AXA in a report on Wednesday, September 11th. Royal Bank of Canada set a €29.50 ($34.30) target price on shares of AXA and gave the company a buy rating in a report on Wednesday, July 31st. Nord/LB set a €27.00 ($31.40) target price on shares of AXA and gave the company a buy rating in a report on Tuesday, August 27th. UBS Group set a €22.00 ($25.58) price objective on shares of AXA and gave the company a neutral rating in a report on Monday, September 9th. Finally, Morgan Stanley set a €26.70 ($31.05) price objective on shares of AXA and gave the company a buy rating in a report on Tuesday, August 6th. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. AXA currently has a consensus rating of Buy and a consensus price target of €26.64 ($30.98).
CS stock opened at €22.91 ($26.63) on Monday. AXA has a 12-month low of €22.13 ($25.73) and a 12-month high of €27.69 ($32.20). The firm has a fifty day moving average price of €21.91.
AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.
Featured Article: Derivative
Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.